Article info

Development of a LAG-3 immunohistochemistry assay for melanoma

Authors

  1. Correspondence to Dr Jeffrey Shuster, Labcorp Drug Development, Morrisville, North Carolina, USA; Jeffrey.Shuster{at}labcorp.com
View Full Text

Citation

Johnson L, McCune B, Locke D, et al
Development of a LAG-3 immunohistochemistry assay for melanoma

Publication history

  • Received March 2, 2022
  • Accepted April 13, 2022
  • First published May 9, 2022.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.